Innovotech Inc
XTSX:IOT

Watchlist Manager
Innovotech Inc Logo
Innovotech Inc
XTSX:IOT
Watchlist
Price: 0.165 CAD -2.94%
Market Cap: 6.7m CAD
Have any thoughts about
Innovotech Inc?
Write Note

Net Margin
Innovotech Inc

-29.7%
Current
-1%
Average
0%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-29.7%
=
Net Income
-364.5k
/
Revenue
1.2m

Net Margin Across Competitors

Country CA
Market Cap 6.6m CAD
Net Margin
-30%
Country US
Market Cap 1.3T USD
Net Margin
9%
Country US
Market Cap 200.7B USD
Net Margin
14%
Country US
Market Cap 172.1B USD
Net Margin
18%
Country KR
Market Cap 67.8T KRW
Net Margin
24%
Country CH
Market Cap 38.6B CHF
Net Margin
9%
Country US
Market Cap 38.8B USD
Net Margin
22%
Country US
Market Cap 36.9B USD
Net Margin
9%
Country US
Market Cap 26.9B USD
Net Margin
21%
Country US
Market Cap 23.4B USD
Net Margin
17%
Country US
Market Cap 23.2B USD
Net Margin
21%
No Stocks Found

Innovotech Inc
Glance View

Market Cap
6.4m CAD
Industry
Life Sciences Tools & Services

Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States and internationally. The company is headquartered in Edmonton, Alberta. The company went IPO on 2003-05-28. The firm's contract research services cover various applications, including implanted devices antimicrobial testing; antibiotic and biocide efficacy screening; agricultural diseases, food safety; dental biofilms; waterline and pipeline fouling; regulatory submission packages; consulting services; and third-party validations. The firm's assays and services include biofilm antimicrobial testing, planktonic antimicrobial testing, aerobic and anaerobic microorganisms as well as bacterial spores. Its products include InnovoSIL Antimicrobial Products, The MBEC Assay, and Agress and AgreGuard. InnovoSIL is a family of antimicrobial agents suited to coating onto or incorporation into medical devices. The MBEC assay is biofilm growth device. Agress and AgreGuard is a seed treatment and plant spray.

IOT Intrinsic Value
0.068 CAD
Overvaluation 59%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-29.7%
=
Net Income
-364.5k
/
Revenue
1.2m
What is the Net Margin of Innovotech Inc?

Based on Innovotech Inc's most recent financial statements, the company has Net Margin of -29.7%.